To investigate the regulatory roles of neutrophil elastase (NE) and matrix metalloproteinase-9 (MMP-9) in lipopolysaccharide (LPS)-induced acute lung injury (ALI) in mice.
Introduction
The pathophysiological characteristics of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) include direct or indirect injury to the alveolar epithelial and capillary endothelial cells, increased permeability of the alveolar-capillary membrane, infiltration of inflammatory cells, and release of inflammatory mediators, which in turn lead to interstitial and alveolar pulmonary edema, oxygenation damage, progressive hypoxemia, and dyspnea. Owing to the severe clinical manifestations, ALI and ARDS have considerably high mortality rates. ALI and ARDS can be induced by a variety of conditions, including sepsis, pancreatitis, ischemia-reperfusion injury, and inhalation injury [1] [2] [3] [4] . However, the exact mechanisms underlying the onset of ALI and ARDS remain unclear. MMPs are closely related to the pathogenesis of lung injury. Among the different types of lung injuries, ALI is known to be closely related to the production of inflammatory mediators from neutrophils and the release of cytotoxic molecules. In particular, the accumulation of neutrophils in the microvasculature of the lung is considered critical to the pathogenesis of ALI.
MMP-9 is a key factor that regulates neutrophil migration and activation. MMP-9 inhibition by MMP inhibitors can reduce neutrophil transmigration. The elevated level of MMP-9 in the bronchoalveolar lavage fluid (BALF) in ALI has been suggested to play a role in neutrophil-mediated ALI and the corresponding inflammatory responses [5] [6] [7] [8] [9] .
Neutrophil elastase (NE) is a protease involved in the processes of tissue remodeling and inflammation that characterize a number of diseases, including hereditary emphysema, chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), ARDS, ischemic-reperfusion injury, and rheumatoid arthritis.
Human NE is a well-characterized serine protease that has been shown to serve as a biomarker of pulmonary inflammation in both α-1 antitrypsin deficiency and CF. The dysregulation or inhibition of NE could repress the pulmonary inflammatory responses in CF and COPD. NE contributes to the pathogenesis of as well as the repair process following ALI and ARDS. In COPD, NE is known to activate MMPs, including MMP-9. However, the exact role of NE in ALI and ARDS is unclear 10, 11 .
In this study, we examined the levels of MMP-9, NE, and inflammatory mediators in the lung tissues and BALF from LPS-induced ALI mice to investigate the role of MMP-9 and the involvement of NE in this pathogenic process.
Methods
All animal experiments had been authorized by the The NEI and CMT collaborative experiments were divided into 4 groups of control (CON), NEI, CMT and NEI+CMT groups that 15 mice were in each group. Lung wet-dry ratio, leukocyte and neutrophil cell count, IL-6, and TNF levels in BALF were detected at time of 48h after administration.
Wild-type C57BL/6 mice were intratracheally neutrophil infiltration, and increased thickness of the alveolar wall, as described in a previous study 12 .
Tissue preparation and measurement of the lung dry/wet weight ratio
A thoracotomy was performed, and the heart and lungs were excised from the mice. The left lung was separated and weighed after ligation of the left main bronchus. The lung was then dried in a drying oven until a constant weight was obtained, and the lung dry/wet weight ratio was then calculated.
BALF analysis
Bronchoalveolar lavage (BAL) was performed using 0.3-ml aliquots of sterile phosphate buffered saline (PBS). After centrifugation, the cells were separated from the supernatant fraction. The BALF samples were then frozen at -80°C. Red blood cells were eliminated from the cell fraction by hypotonic lysis, and the cell-free supernatant was harvested. Each lung was lavaged with three aliquots of sterile saline. The total and differential white blood cell (WBC) counts of the BAL cells were performed. The lung was then removed and its water content was measured on the basis of the lung dry/wet weight ratio. A blood sample was obtained by cardiac puncture.
The cell-free BALF samples harvested from the mice in each group, namely, control (sham), LPS, LPS + NEI, LPS + CMT, LPS + NEI + CMT, control + NEI, control + CMT, and control + NEI + CMT, were analyzed in triplicate for WBC count, polymorphonuclear (PMN) count, and interleukin (IL)-6 and tumor necrosis factor (TNF) levels, using commercially available ELISA kits. The results were expressed as pg/BAL after correcting for the volume of BALF that was recovered from each mouse (≥ 3.0 ml of BALF was recovered from a total of 4 ml PBS administered to each mouse).
Real-time polymerase chain reaction
Mice were sacrificed and dissected immediately after a lethal dose of anesthesia. Total RNA was isolated from their lungs. For each reaction, 0.5 μg of RNA was reverse transcribed using the Omniscript reverse transcriptase kit (Qiagen, Inc., Valencia, CA, USA) according to the manufacturer's protocol. Primers for the specific detection of MMP-9, IL-6, and tissue inhibitor of metalloproteinase-1 (TIMP-1) were designed using the Real-Time Polymerase Chain Reaction (PCR) software (Integrated DNA Technologies, Inc., Coralville, IA, USA). The sequences of these primers were as follows: MMP-9 (NM013599): 3′-GATCCCCAGAGCGTCATTC-5′, 3′-CCACCTTGTTCACCTCATTTTG-5′; TIMP-1 (NM011593):
3′-CTCAAAGACCTATAGTGCTGGC-5′, 3′-CAAAGTGACGCTCTGGTAG-5′; IL-6 (NM031168):
5′-TGGAATCCTGTGGCATCCATGAA-3′, 5′-TAAAACGCAGCTCAGTAACAGTC-3′. The thermal cycling conditions entailed the following steps: 1) polymerase activation at 95°C for 3 min; 2) 45 cycles of denaturation at 95°C for 10 s followed by annealing and extension at 60°C for 30 s; and 3) generation of a DNA melting curve for determining amplicon specificity. All experiments were performed in duplicate. For each PCR reaction, the sample was amplified in triplicate on an Applied Biosystems 7500 Real-Time PCR System (Applied Biosystems, Foster City, CA, USA). β-Actin was used as the internal control. The relative levels of each examined gene were calculated according to the manufacturer's instructions.
Survival analysis
Survival analysis was performed on the mice in each group over a period of 5 d (120 h), and the survival rate was calculated accordingly. Data were expressed as mean ± SEM. Intergroup differences were evaluated by one-way ANOVA using LPS or saline treatment as a factor. P<0.05 was considered statistically significant.
Results

MMP-9 and TIMP-1 expression and ratio of MMP-9/TIMP-1
An ALI mouse model was established by intratracheal administration of LPS in C57BL/6 mice. Lung tissue samples
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were obtained from these mice with a lethal dose of anesthesia at the indicated times of 6 h, 24 h, or 48 h after administration of LPS and/or NEI. Total RNA was extracted from these samples and used for the detection of MMP-9, IL-6, and TIMP-1 mRNA expression and for the determination of the MMP-9/TIMP-1 ratio in the lung tissues in ALI mice. Our results showed that the expression level of MMP-9 was significantly elevated in the lung tissues obtained from LPS-induced ALI mice compared to that in the lung tissues obtained from control mice, in a time-dependent manner. Moreover, the expression of the natural MMP-9 inhibitor TIMP-1 and the ratio of MMP-9/TIMP-1 in the LPS-treated group of mice were significantly higher than those in the sham group ( Figure 1) . 
Regulation of expression of MMP-9, TIMP-1, and IL-6
Lung tissue samples were obtained from mice in the LPS and LPS + NEI groups at the time points of 6 h, 24 h and 48 h after administration of LPS and/or NEI. The expression of NE, MMP-9, TIMP-1, and IL-6 mRNA and the ratio of MMP-9/TIMP-1 in these samples were examined. The results showed that the expression of NE, MMP-9, and IL-6 was significantly downregulated in a timedependent manner in the LPS + NEI group as compared to that in the LPS group. In the control group, NEI treatment did not show any significant difference in TIMP-1 expression (Figure 1) .
Role of NE and MMP-9 in pulmonary edema, neutrophil infiltration, and regulation of expression of inflammatory mediators
The left lungs from mice in the LPS, LPS + NEI, and LPS + CMT groups were excised after a lethal dose of anesthesia, and BALF was obtained for calculation of the lung dry/wet weight ratio and for WBC count and PMN count at time of 48h after administration of LPS and/or NEI. The results showed that the lung dry/wet weight ratio in the LPS + NEI and LPS + CMT groups was significantly lower than that in the LPS group. Moreover, the WBC count, PMN count, and the expression of inflammatory mediators IL-6 and TNF in the BALF from the LPS + NEI and LPS + CMT groups were significantly lower than those in the BALF from the LPS group (Figures 2 and 3) . 
Discussion
Previous studies have shown that neutrophil infiltration and inflammatory mediator release play important roles in ALI induced by injury to the pulmonary microcirculation and alveolar-
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The results of BALF analysis showed that treatment with both NEI and CMT significantly reduced the WBC and PMN counts, indicating that both NE and MMP-9 could regulate the activation and accumulation of inflammatory cells in LPS-induced ALI. In addition, treatment with both NEI and CMT significantly reduced the weight of lungs with ALI, which indicated the role of NE and MMP-9 in the development of pulmonary edema in ALI.
Survival analysis showed that combined treatment with NEI and CMT significantly improved the survival rate of ALI mice.
Conclusions
Lipopolysaccharide treatment induced the expression of neutrophil elastase and matrix metalloproteinase-9, and the activation and accumulation of inflammatory cells in acute lung injury mouse models. NE may regulate the expression of MMP-9
and the ratio of MMP-9/TIMP-1, thereby regulating the expression and release of inflammatory mediators, leading to pulmonary edema and lung injury, and consequently affecting the survival rate of ALI mice.
